/ Not yet recruiting临床3期IIT A EUROpean Pragmatic Multicenter Randomized Trial on Platelet Inhibition and/or Lipid Lowering Treatment in Covert Brain Infarction (CBI)
Magnetic resonance imaging (MRI) is commonly used in healthcare, and sometimes it shows small areas of brain damage called Covert Brain Infarcts (CBIs). These are usually found by chance when people have scans for things like headaches or dizziness. Although CBIs don't cause symptoms at the time, they are linked to a higher risk of future stroke and death.
There is currently no standard treatment for CBIs, and doctors have different approaches-some give stroke-preventing medication (like antiplatelets or statins), while others don't treat at all. This is mostly because there isn't enough research yet.
This study will test whether stroke-preventing treatments help people with CBIs. It will also look at whether having a CBI increases the risk of dementia, and whether treatment might lower that risk.
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Atherosclerotic Stenosis Patients: A Multicenter Cohort Study
The purpose of this study is to explore the mechanism of cognitive impairment in patients with symptomatic intracranial atherosclerotic stenosis (ICAS), and further plans to explore the impact of different treatment options on cognitive function in symptomatic ICAS patients.
A national wide CrossSectional Survey to evaluate the Knowledge,Attitude, and Practices (KAP) on Triple Combination Therapy ofRosuvastatin 10/20 mg Plus Aspirin 75 mg Plus Clopidogrel 75 mg) amongHealth Care professionals in India (KASPER). - KASPER
100 项与 COX-1 x COX-2 x HMGCR x P2Y12 receptor x TBXA2R 相关的临床结果
100 项与 COX-1 x COX-2 x HMGCR x P2Y12 receptor x TBXA2R 相关的转化医学
0 项与 COX-1 x COX-2 x HMGCR x P2Y12 receptor x TBXA2R 相关的专利(医药)